One-Shot malaria shield? new combo drug aims to stop silent infections
NCT ID NCT05974267
Summary
This study tested whether a single dose of two drugs (M5717 and pyronaridine) could clear existing silent malaria infections and then protect people from getting infected again. It involved 192 asymptomatic adults and adolescents who already had the malaria parasite in their blood but felt fine. Researchers measured how long the protection lasted and checked the safety of the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Groupe de Recherche Action en Sante (GRAS)
Ouagadougou, Burkina Faso
-
Kisumu County Referral Hospital
Kisumu, Kenya
-
MRC Unit The Gambia at LSHTM
Banjul, The Gambia
-
Ndola Teaching Hospital
Ndola, Zambia
Conditions
Explore the condition pages connected to this study.